Glycated haemoglobin for the diagnosis of diabetes

d'Emden, MIchael (2014) Glycated haemoglobin for the diagnosis of diabetes. Australian Prescriber, 37 3: 98-100.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ333414_OA.pdf Full text (open access) application/pdf 106.45KB 22
Author d'Emden, MIchael
Title Glycated haemoglobin for the diagnosis of diabetes
Journal name Australian Prescriber   Check publisher's open access policy
ISSN 0312-8008
Publication date 2014
Year available 2014
Sub-type Article (original research)
Open Access Status File (Publisher version)
Volume 37
Issue 3
Start page 98
End page 100
Total pages 3
Place of publication Deakin, ACT Australia
Publisher Australian Government Publishing Service
Collection year 2015
Language eng
Formatted abstract
The development of specific diabetes complications correlates with glycated haemoglobin (HbA1c), the most accepted measure of chronic glycaemia.  An HbA1c of 48 mmol/mol (6.5%) or greater has now been recommended in Australia for diagnosis of type 2 diabetes.  The HbA1c test should greatly simplify the diagnostic pathway, negating the need for oral glucose
tolerance tests in the majority of patients. However, improved performance and precision of the assay with its standardisation across Australia is required.  Many clinical situations can impact on the HbA1c assay and the clinician needs to be aware of
these if it is to be used appropriately for diagnosis.
Keyword Blood glucose
Diabetic retinopathy
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Non HERDC
Official Audit
School of Medicine Publications
Version Filter Type
Citation counts: Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Tue, 24 Jun 2014, 02:49:09 EST by System User on behalf of Medicine - Royal Brisbane and Women's Hospital